Relationship between Serum Level of Interleukin 22 and Severity of Liver Disease in Patients with Chronic Hepatitis C Virus

Antony Fayez Zaky Abboud;

Abstract


ABSTRACT
Background: HCV is one of the leading agents that cause liver failure, and hepatocellular carcinoma and is the most relevant reason for liver transplantation. HCV infects about 3% of the world population; 130–200 million people are estimated to be chronically infected globally. Alarming news is that 350,000 people worldwide die from HCV-related disease every year . For more than 20 years, HCV has been taking the attention of the health professionals, and now, well recognized that HCV is actually a major global health problem.
Aim of The Work: The aim of this study is to measure the serum level of interleukin 22 in chronic hepatitis C patients and its relationship with severity of the liver disease.


Other data

Title Relationship between Serum Level of Interleukin 22 and Severity of Liver Disease in Patients with Chronic Hepatitis C Virus
Other Titles العلاقة بين مستوي الانترليوكين 22 فى الدم ومدي اصابة الكبد في مرضي الالتهاب الكبدي الوبائي الفيروسي سي المزمن
Authors Antony Fayez Zaky Abboud
Issue Date 2018

Attached Files

File SizeFormat
J6764.pdf349.61 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 3 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.